EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation

Nanami Gotoh iD, Tsukasa Oda iD, Yuya Kitamura, Natsuki Shiraishi, Runa Aoyagi, Ayane Omori, Kota Yanagisawa, Minami Iida, Yua Itoi, Hikaru Negishi, Ikuko Matsumura, Tetsuhiro Kasamatsu iD und 7 weitere

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.14401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Nanami Gotoh und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Science, Graduate School of Health Sciences, Gunma University, Maebashi, Japan. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, DNA-(Apurinic or Apyrimidinic Site) Lyase, Cell Proliferation, Cell Differentiation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KAKENHI, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The link between DNA repair gene polymorphisms and cancer susceptibility has gained significant attention. Thus, we investigated the impact of base excision repair (BER) gene polymorphisms on acute myeloid leukemia (AML) risk and pathogenesis.

Methods

In total, 106 patients with AML and 191 healthy controls were included in the study, wherein polymorphisms in four BER genes ( APEX1 , MUTYH , OGG1 , and XRCC1 ) were examined.

Results

Notably, the APEX1 ‐656 T>G polymorphism exhibited a significant association with AML risk in the recessive (TT vs. TG + GG) ( p = 0.046) and co‐dominant models (TT vs. GG) ( p = 0.02). Assessing APEX1 expression levels, APEX1 expression was elevated in the bone marrow of patients with AML compared with that in controls ( p = 0.02). Subsequently, we compared the percentages of CD34+ cells between the APEX1 high or low expression groups, revealing a significant difference (high vs. low = 29.9% vs. 11.5%, p = 0.01). Additionally, we observed reduced APEX1 expression in HL60 cells differentiated with all‐trans retinoic acid ( p < 0.001). We hypothesized that APEX1 expression could correlate with stemness and analyzed its expression in stem and differentiated cells.

Conclusions

In the GSE48558 dataset, AML cells and normal CD34+ cells expressed APEX1 at higher levels than did granulocytes ( p < 0.01). Functional experiments revealed that APEX1 knockdown led to a reduction in AML cell proliferation. These findings indicated that APEX1 polymorphisms were a potential risk factor for AML and highlighted the important role of APEX1 in regulating AML cell differentiation and proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteDNA-(Apurinic or Apyrimidinic Site) LyaseCell ProliferationCell DifferentiationGenetic Predisposition to DiseaseGene Expression Regulation, LeukemicPolymorphism, Single NucleotideHumansMaleFemaleMiddle AgedAdultAgedCase-Control Studies

Stichwörter der Autor:innen

acute myeloid leukemiabase excision repairdifferentiationexpressionpolymorphism

Substanzen

DNA-(Apurinic or Apyrimidinic Site) LyaseAPEX1 protein, human

Autor:innen und Institutionen

  • Department of Laboratory Science, Graduate School of Health Sciences, Gunma University, Maebashi, Japan.
  • Laboratory of Mucosal Ecosystem Design, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
  • Department of Hematology, Graduate School of Medicine, Gunma University, Maebashi, Japan.
  • Leukemia Research Centre, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Division of Blood Transfusion Service, Gunma University Hospital, Maebashi, Japan.
  • Faculty of Medical Technology and Clinical Engineering, Gunma University of Health and Welfare, Maebashi, Japan.

ORCID-Profile: Nanami Gotoh, Tsukasa Oda, Tetsuhiro Kasamatsu, Eiji Miyauchi, Nobuo Sasaki, Hiroshi Handa, Takayuki Saitoh

Förderung

  • KAKENHI
  • Japan Society for the Promotion of Science

Zitieren

APA

Gotoh, N., Oda, T., Kitamura, Y., Shiraishi, N., Aoyagi, R., Omori, A., Yanagisawa, K., Iida, M., Itoi, Y., Negishi, H., Matsumura, I., Kasamatsu, T., Miyauchi, E., Sasaki, N., Takada, S., Yokohama, A., Handa, H., Murakami, H., & Saitoh, T. (2025). APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14401

Vancouver

Gotoh N, Oda T, Kitamura Y, Shiraishi N, Aoyagi R, Omori A, et al. APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14401

BibTeX
@article{Gotoh2025,
  author = {Gotoh, Nanami and Oda, Tsukasa and Kitamura, Yuya and Shiraishi, Natsuki and Aoyagi, Runa and Omori, Ayane and Yanagisawa, Kota and Iida, Minami and Itoi, Yua and Negishi, Hikaru and Matsumura, Ikuko and Kasamatsu, Tetsuhiro and Miyauchi, Eiji and Sasaki, Nobuo and Takada, Satoru and Yokohama, Akihiko and Handa, Hiroshi and Murakami, Hirokazu and Saitoh, Takayuki},
  title = {APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.14401}
}
Kostenlos starten →